Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[AL amyloidosis]

T Isobe1

  • 1Faculty of Health Science, Kobe University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|March 1, 1995
PubMed
Summary
This summary is machine-generated.

AL amyloidosis, a systemic disease involving immunoglobulin light chains, requires pathological diagnosis. Early detection is crucial due to its poor prognosis compared to myeloma.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dipole Strength Distribution of ^{8}He and Decay Characteristics.

Physical review letters·2026
Same author

Identification of a universal three-body s-wave resonance in <sup>10</sup>He.

Nature communications·2026
Same author

Few-Electron Highly Charged Muonic Ar Atoms Verified by Electronic K X Rays.

Physical review letters·2025
Same author

Seniority Structure in Neutron-Rich Nucleus ^{128}Ag: Evidence for Robustness of N=82 Shell Closure in Silver Isotopes.

Physical review letters·2025
Same author

Isospin Symmetry Breaking in the ^{71}Kr and ^{71}Br Mirror System.

Physical review letters·2025
Same author

Efficacy of pembrolizumab in microsatellite-stable, tumor mutational burden-high metastatic colorectal cancer: genomic signatures and clinical outcomes.

ESMO open·2025
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Area of Science:

  • Hematology
  • Oncology
  • Pathology

Context:

  • AL amyloidosis is a systemic disease characterized by immunoglobulin light chain deposition.
  • It is associated with plasma cell dyscrasia or monoclonal gammopathy.
  • Clinical manifestations include macroglossia, cardiac, ECG, and GI abnormalities, and carpal tunnel syndrome.

Purpose:

  • To highlight the diagnostic criteria for AL amyloidosis.
  • To differentiate AL amyloidosis from myeloma based on immunoglobulin distributions.
  • To emphasize the critical need for early diagnosis due to survival differences.

Summary:

  • Diagnosis relies on patho-histological Congo-red stains of biopsied tissues.
  • AL amyloidosis involves monoclonal Ig's in serum/urine, with a higher incidence of Bence Jones proteins and lambda chains.

Related Experiment Videos

  • Median survival is significantly shorter (12 months) than in myeloma (36 months), especially with cardiac involvement (4 months).

    • Impact:

    • Underscores the importance of recognizing AL amyloidosis symptoms for timely intervention.
    • Emphasizes the need for further research into early diagnostic methods.
    • Aims to improve patient outcomes by facilitating earlier detection and treatment strategies.